Ignite Creation Date:
2024-05-06 @ 4:55 PM
Last Modification Date:
2024-10-26 @ 2:18 PM
Study NCT ID:
NCT05132218
Status:
RECRUITING
Last Update Posted:
2021-11-24
First Post:
2021-10-26
Brief Title:
Ensatinib in alK-positive Patients Undergoing Initial Treatment for Advanced Non-small Cell Lung Cancer
Sponsor:
Peking University Cancer Hospital Institute
Organization:
Peking University Cancer Hospital Institute
Organization Data
Organization:
Peking University Cancer Hospital Institute
Class:
OTHER
Study ID:
BD-EN-IV002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Peking University Cancer Hospital Institute
Lead Sponsor Class:
OTHER
Responsible Party:
Jun Zhao
Responsible Party Title:
Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Peking University Cancer Hospital Institute
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Betta Pharmaceuticals Co Ltd | INDUSTRY |